2020
DOI: 10.1038/s41588-020-00740-8
|View full text |Cite
|
Sign up to set email alerts
|

Improving the trans-ancestry portability of polygenic risk scores by prioritizing variants in predicted cell-type-specific regulatory elements

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
145
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 151 publications
(157 citation statements)
references
References 63 publications
5
145
0
Order By: Relevance
“…Many recent efforts have demonstrated that functional annotation of the reference genome improves the fine-mapping of disease variants (55)(56)(57)(58). The unique advantage of EN-TEx is that the genetic variants and their functional annotations are determined for the same individual.…”
Section: Discussionmentioning
confidence: 99%
“…Many recent efforts have demonstrated that functional annotation of the reference genome improves the fine-mapping of disease variants (55)(56)(57)(58). The unique advantage of EN-TEx is that the genetic variants and their functional annotations are determined for the same individual.…”
Section: Discussionmentioning
confidence: 99%
“…Characterization of these variants will allow a better understanding of gene regulation and disease etiology. Indeed, mounting evidence suggests that genetic variants underlying disease associations are often context-specific [8][9][10][11][12][13][14][15][16]. For example, the Immune Variation project identified eQTLs in monocytederived dendritic cells and human CD4+ T lymphocytes with different effects in response to in vitro stimulation and polarization [13,17].…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, recent empirical work on within-family disease risk prediction showed that the reduction in accuracy is at most modest (Lello et al, 2020), and within-siblings-GWAS yielded similar results to unrelated-GWAS for most physiological traits (Howe et al, 2021). Additionally, accuracy in non-European populations is rapidly improving due to the establishment of national biobanks in non-European countries (Koyama et al, 2020;Vujkovic et al, 2020) and improvement in methods for transferring scores into non-European populations (Amariuta et al, 2020;Cai et al, 2021). Either way, the analytical results presented in this paper are formulated generally as a function of the achievable accuracy 2 , and as such, users can substitute values relevant to their specific target population and disease.…”
Section: Discussionmentioning
confidence: 99%